How are the European pharma and biotech sectors addressing strategic communications?Stakeholder expectations are high and, with all eyes on healthcare at the moment, it is essential for companies Share XHow are the European pharma and biotech sectors addressing strategic communications?https://deep-dive.pharmaphorum.com/magazine/communications-and-commercialisation/european-pharma-biotech-strategic-communications/
BMS’ Catherine Owen: Hybrid communication is here to stayThe company’s senior vice president for major markets (Europe, Canada and Japan) talks about the continued evolution of Share XBMS’ Catherine Owen: Hybrid communication is here to stayhttps://deep-dive.pharmaphorum.com/magazine/communications-and-commercialisation/bristol-myers-squibb-bms-catherine-owen/
A Life in a Day by The MethodPatient centricity has become a key aspiration for the pharma industry over the last several years, but getting Share XA Life in a Day by The Methodhttps://deep-dive.pharmaphorum.com/magazine/communications-and-commercialisation/the-method-patient-empathy-engagement/
Translating EU presence to US market successCompanies looking to replicate a drug’s EU market success in the US will face significant hurdles unless they Share XTranslating EU presence to US market successhttps://deep-dive.pharmaphorum.com/magazine/communications-and-commercialisation/eu-us-pharma-market-success/
BMS’ Catherine Owen on pharma commercialisation: the pharmaphorum podcastEpisode 42 of the pharmaphorum podcast heard from Catherine Owen, who’s senior vice president of major markets at Share XBMS’ Catherine Owen on pharma commercialisation: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/bms-catherine-owen-pharma-commercialisation/
Navigating the patient maze – pharma’s evolving challengePharma companies are embracing patient centricity in drug development more than ever before. Over the last decade, leaders Share XNavigating the patient maze – pharma’s evolving challengehttps://deep-dive.pharmaphorum.com/magazine/communications-and-commercialisation/patient-pharma-engagement-drug-development/
Launch excellence: escaping the complexity trapIQVIA’s Sarah Rickwood and Markus Gores look at how to deliver consistent launch performance in an increasingly complex Share XLaunch excellence: escaping the complexity traphttps://pharmaphorum.com/sales-marketing/launch-excellence-escaping-the-complexity-trap/
It’s time to rethink the physician-pharma relationshipThe traditional sales channel for the pharmaceutical industry has centered on face-to-face interaction with its core target audience Share XIt’s time to rethink the physician-pharma relationshiphttps://deep-dive.pharmaphorum.com/magazine/communications-and-commercialisation/physician-pharma-relationships/
Refining digital collaborationPharmaceutical companies are traditionally more conservative with their approach to and incorporation of new technologies; however, prior to Share XRefining digital collaborationhttps://deep-dive.pharmaphorum.com/magazine/communications-and-commercialisation/pharma-hcp-digital-collaboration/
